SDC Transitions its Ophthalmic Biometric Division to Ora Inc.

Statistics & Data Corporation (SDC) has decided to transition its ophthalmic biometric division to its partner Ora Inc. 

Since 2005, SDC’s partnership and common ownership with Ora has provided clinical trial services in ophthalmology, while allowing SDC to expand its offerings in other therapeutic areas and technology. 

"The transition of our ophthalmic biometric division signifies our unwavering dedication to excellence and innovation in clinical research services and technology solutions. This strategic shift allows SDC to better leverage our core strengths and deliver greater value to our clients and clinical partnerships," Dr. Richard Abelson, CEO of SDC, said in a company news release.

"This strategic move enables us to focus our resources and invest more effectively in technology development and optimization that will drive the next generation of clinical research solutions," said Faith Kolb, COO of SDC.

SDC’s tech-enabled service offering brings to market an AI/ML enabled clinical ecosystem to unify disparate technologies into a single data lake (SDC DataHub) and a single point-of-access reporting platform (SDC Insights), paired with a mobile ePRO/eCOA solution (SDC Capture). This solution is designed to give clients the flexibility to choose the right fit technologies for their clinical trial and not being forced into one eClinical Platform.

The transition of the ophthalmic biometric division will not disrupt ongoing projects or client relationships, SDC stated.